Oil traders are worried about a potential slowdown of the U.S. economy.

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Elastic N.V. ("Elastic" or the "Company") (NYSE: ESTC) of a class action securities lawsuit.

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Block, Inc. ("Block" or the "Company") (NYSE: XYZ) of a class action securities lawsuit.

SAN FRANCISCO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Investors in Block, Inc. (NYSE: SQ) n/k/a (NYSE: XYZ) began to learn of potentially adverse information about the company and its Square and Cash App platforms on Mar. 23, 2023, when Hindenburg Research published a scathing report on the company.

CHICAGO--(BUSINESS WIRE)--Hyatt Centric expects to grow its footprint by 50 percent by the end of 2028 with artistically curated spaces that inspire exploration.

On Thursday, Guardant Health GH reported fourth-quarter adjusted EPS loss of 62 cents, compared to a loss of 64 cents a year ago, beating the consensus loss of 74 cents.

Bausch + Lomb reported solid Q4 and full-year 2024 earnings, with CEO Brent Saunders highlighting positives while avoiding the critical issue of Bausch Health's potential sale of its 88% stake. The company's performance review for 2024 was strong, but the future share price trajectory hinges on whether Bausch Health will divest its majority ownership. Investors are closely watching Bausch Health's decision, as it remains the key factor influencing Bausch + Lomb's market valuation and investor sentiment.

On Friday, Exelixis, Inc. EXEL authorized repurchasing up to an additional $500 million of the company's common stock before December 31, 2025.

SAN FRANCISCO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is facing headwinds on multiple fronts, including disappointing sales figures, ongoing legal challenges, and analyst downgrades. TD Cowen recently lowered its price target for Regeneron to $1,030 from $1,230, citing increased competition and lower revenue estimates for EYLEA®, a key product.

SAN FRANCISCO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Cardlytics, the advertising technology company that connects marketers with consumers through their banking apps, is facing a class-action lawsuit alleging that it misled investors about its growth prospects.

NEW YORK CITY, NY / ACCESS Newswire / February 21, 2025 / NEW YORK, NY / ACCESS Newswire / February 21, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Liberty Broadband Corp ("LBRDA" or the "Company") (NASDAQ:LBRDA) stock purchased prior to September 22, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Liberty and Charter Communications, Inc. ("Charter"), whether the Board of LBRDA harmed stockholders by agreeing to enter into this transaction, and whether all material …

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Aspen Technology Inc. ("AZPN" or the "Company") (NASDAQ:AZPN) stock purchased prior to January 27, 2025. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Aspen Technology Inc. and Emerson Electric (EMR), whether the Board of AZPN have harmed stockholders by agreeing to enter into this transaction, and whether all material facts have been properly disclosed to stockholders.

NEW YORK CITY, NY / ACCESS Newswire / February 21, 2025 / WHY: New York, N.Y., February 21, 2025.

SAN DIEGO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. (NASDAQ: TMDX) publicly traded securities between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”), have until April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit. Captioned Jewik v. TransMedics Group, Inc., No. 25-cv-10385 (D. Mass.), the TransMedics class action lawsuit charges TransMedics as well as certain of TransMedics' top executives with violations of the Securities Exchange Act of 1934.

On Thursday, Insulet Corporation PODD reported fourth-quarter adjusted EPS of $1.15, down from $1.40 a year ago but beating the consensus of $1.02.

SAN FRANCISCO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Napco Security Technologies, Inc. (NASDAQ: NSSC) saw its shares tumble after the company reported a sharp decline in second-quarter 2025 earnings, revealing problems with its distribution network. The news reignited concerns about the company's sales practices, previously raised by a research report last September.

Instacart CEO Fidji Simo told CNBC's Julia Boorstin that there is a need for both masculine and feminine energy in the workplace. There is considerable blowback right now against diversity efforts in the market, including from Simo's own former boss Mark Zuckerberg at Meta, where DEI programs have been scrapped and Zuckerberg has recently called for more “masculine energy” in the workplace.

JP Morgan analyst Rajat Gupta downgraded TrueCar, Inc. TRUE from Overweight to Neutral.

Comfort Systems USA, Inc. (NYSE:FIX ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Corporate Participants Julie Shaeff - Chief Accounting Officer Brian Lane - President and Chief Executive Officer Bill George - Chief Financial Officer Conference Call Participants Brent Thielman - D.A. Davidson Adam Thalhimer - Thompson Davis Julio Romero - Sidoti & Company Josh Chan - UBS Brian Brophy - Stifel Alex Dwyer - KeyBanc Capital Markets Khadir Richie - Richie Capital Group Operator Good day and thank you for standing by.

SAN FRANCISCO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI) is facing mounting pressure after a second activist short-seller, Snowcap, released a critical report on January 29, 2025, further amplifying concerns initially raised by Muddy Waters Research earlier in January and leading to an investor class action alleging securities fraud.